Related references
Note: Only part of the references are listed.Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromes
Bing Li et al.
GENES CHROMOSOMES & CANCER (2018)
U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlates
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Mutations and prognosis in myelodysplastic syndromes: karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model
Naseema Gangat et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management
Guillermo Montalban-Bravo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes
Bon Ham Yip et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes
Lingyun Wu et al.
TUMOR BIOLOGY (2016)
Short telomere length and its correlation with gene mutations in myelodysplastic syndrome
Sang Mee Hwang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Mutations of myelodysplastic syndromes (MDS): An update
Bani Bandana Ganguly et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2016)
The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts
Min-Gu Kang et al.
BMC CANCER (2015)
Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo
Cara Lunn Shirai et al.
CANCER CELL (2015)
U2AF1 mutations alter splice site recognition in hematological malignancies
Janine O. Ilagan et al.
GENOME RESEARCH (2015)
U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing
T. Okeyo-Owuor et al.
LEUKEMIA (2015)
A Pan-Cancer Analysis of Transcriptome Changes Associated with Somatic Mutations in U2AF1 Reveals Commonly Altered Splicing Events
Angela N. Brooks et al.
PLOS ONE (2014)
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
Shang-Ju Wu et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms
Bartlomiej Przychodzen et al.
BLOOD (2013)
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
M. J. Walter et al.
LEUKEMIA (2013)
Mutations affecting mRNAsplicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
Frederik Damm et al.
BLOOD (2012)
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
Felicitas Thol et al.
BLOOD (2012)
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
Hideki Makishima et al.
BLOOD (2012)
Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
Rafael Bejar et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders
V. Visconte et al.
LEUKEMIA (2012)
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
Timothy A. Graubert et al.
NATURE GENETICS (2012)
U2AF1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
Jun Qian et al.
PLOS ONE (2012)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)